Gene expression patterns in bone following lipopolysaccharide stimulation

Cellular and Molecular Biology Letters

Volumn 19, Issue 4, 2014, Pages 611-622

  Yang, Jing ^a   Su, Nan ^a   Du, Xiaolan ^a   Chen, Lin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone; Bone morphogenetic protein 2; Core binding factor 1; Inflammation; Lipopolysaccharide; Microarray; Mouse; N terminal propeptide of type I collagen; Osteocalcin; Osteogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; CYCLOPHILIN A; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; AUTACOID; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; FEMUR; GENE ONTOLOGY; IMMUNOLOGY; METABOLISM; OSTEOBLAST;

ANIMALS; FEMUR; GENE ONTOLOGY; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; OSTEOBLASTS; PEPTIDE FRAGMENTS; PROCOLLAGEN; TRANSCRIPTOME;

EID: 84922002775     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-014-0216-2     Document Type: Article

References (29)

1. Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., Milner, L.A., Kronenberg, H.M. and Scadden, D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature425 (2003) 841–846. DOI: 10.1038/nature02040.
2. Riedemann, N.C., Guo, R.F. and Ward, P.A. Novel strategies for the treatment of sepsis. Nat. Med.9 (2003) 517–524. DOI: 10.1038/nm0503-517.
3. Walsh, M.C., Kim, N., Kadono, Y., Rho, J., Lee, S.Y., Lorenzo, J. and Choi, Y. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol.24 (2006) 33–63. DOI: 10.1146/annurev.immunol.24.021605.090646.
4. Lee, N.K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J.D., Confavreux, C., Dacquin, R., Mee, P.J., McKee, M.D., Jung, D.Y., Zhang, Z., Kim, J.K., Mauvais-Jarvis, F., Ducy, P., Karsenty, G. Endocrine regulation of energy metabolism by the skeleton. Cell130 (2007) 456–469. DOI: 10.1016/j.cell.2007.05.047.
5. Nair, S.P., Meghji, S., Wilson, M., Reddi, K., White, P. and Henderson, B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun.64 (1996) 2371–2380.
6. Zhuang, L., Jung, J.Y., Wang, E.W., Houlihan, P., Ramos, L., Pashia, M. and Chole, R.A. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope117 (2007) 841–847. DOI: 10.1097/MLG.0b013e318033783a.
7. Grimm, G., Vila, G., Bieglmayer, C., Riedl, M., Luger, A. and Clodi, M. Changes in osteopontin and in biomarkers of bone turnover during human endotoxemia. Bone47 (2010) 388–391. DOI: 10.1016/j.bone.2010.04.602.
8. Abu-Amer, Y., Ross, F.P., Edwards, J. and Teitelbaum, S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest.100 (1997) 1557–1565. DOI: 10.1172/JCI119679.
9. Lowik, C.W., Nibbering, P.H., van de Ruit, M. and Papapoulos, S.E. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J. Clin. Invest.93 (1994) 1465–1472. DOI: 10.1172/JCI117124.
10. Nakamura, T., Kawagoe, Y., Matsuda, T. and Koide, H. Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med.30 (2004) 1838–1841. DOI: 10.1007/s00134-004-2357-7.
11. Zhang, Y., Xue, C., Zhu, T., Du, X., Su, N., Qi, H., Yang, J., Shi, Y. and Chen, L. Serum bone alkaline phosphatase in assessing illness severity of infected neonates in the neonatal intensive care unit. Int. J. Biol. Sci.8 (2012) 30–38.
12. Kadono, H., Kido, J., Kataoka, M., Yamauchi, N. and Nagata, T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect. Immun.67 (1999) 2841–2846.
13. Xing, Q., Ye, Q., Fan, M., Zhou, Y., Xu, Q. and Sandham, A. Porphyromonas gingivalis lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activating Notch1 signaling. J. Cell. Physiol.225 (2010) 106–114. DOI: 10.1002/jcp.22201.
14. Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J. and Nanes, M.S. Inhibition of osteoblast differentiation by tumor necrosis factoralpha. Endocrinology141 (2000) 3956–3964. DOI: 10.1210/endo.141.11.7739.
15. Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., van Wijnen, A.J., Lian, J.B., Stein, G.S. and Nanes, M.S. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J. Biol. Chem.277 (2002) 2695–2701. DOI: 10.1074/jbc.M106339200.
16. Ding, J., Ghali, O., Lencel, P., Broux, O., Chauveau, C., Devedjian, J.C., Hardouin, P. and Magne, D. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci.84 (2009) 499–504. DOI: 10.1016/j.lfs.2009.01.013.
17. Smith, D.D., Gowen, M. and Mundy, G.R. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology120 (1987) 2494–2499. DOI: 10.1210/endo-120-6-2494.
18. Canalis, E. Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology118 (1986) 74–81. DOI:10.1210/endo-118-1-74.
19. Centrella, M., McCarthy, T.L. and Canalis, E. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology123 (1988) 1442–1448. DOI: 10.1210/endo-123-3-1442.
20. Tsuboi, M., Kawakami, A., Nakashima, T., Matsuoka, N., Urayama, S., Kawabe, Y., Fujiyama, K., Kiriyama, T., Aoyagi, T., Maeda, K. and Eguchi, K. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J. Lab. Clin. Med.134 (1999) 222–231.
21. Christiansen, J.H., Coles, E.G. and Wilkinson, D.G. Molecular control of neural crest formation, migration and differentiation. Curr. Opin. Cell. Biol.12 (2000) 719–724.
22. Zhang, H. and Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development122 (1996) 2977–2986.
23. Wall, N.A. and Hogan, B.L. TGF-beta related genes in development. Curr. Opin. Genet. Dev.4 (1994) 517–522.
24. Rosen, V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev.20 (2009) 475–480. DOI:10.1016/j.cytogfr. 2009.10.018.
25. Liu, T., Gao, Y., Sakamoto, K., Minamizato, T., Furukawa, K., Tsukazaki, T., Shibata, Y., Bessho, K., Komori, T. and Yamaguchi, A. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J. Cell Physiol.211 (2007) 728–735. DOI: 10.1002/jcp.20988.
26. Zamurovic, N., Cappellen, D., Rohner, D. and Susa, M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J. Biol. Chem.279 (2004) 37704–33715. DOI: 10.1074/jbc.M403813200.
27. Bedford, L., Walker, R., Kondo, T., van Cruchten, I., King, E.R. and Sablitzky, F. Id4 is required for the correct timing of neural differentiation. Dev. Biol.280 (2005) 386–395. DOI: 10.1016/j.ydbio.2005.02.001.
28. Rivera, R. and Murre, C. The regulation and function of the Id proteins in lymphocyte development. Oncogene20 (2001) 8308–8316. DOI: 10.1038/sj.onc.1205091.
29. Huang, R.L., Yuan, Y., Zou, G.M., Liu, G., Tu, J. and Li, Q. LPS-stimulated inflammatory environment inhibits BMP-2-induced osteoblastic differentiation through crosstalk between TLR4/MyD88/NF-kappaB and BMP/Smad signaling. Stem Cells Dev.23 (2014) 277–289. DOI: 10.1089/scd.2013.0345.